Chembio Diagnostic
Chembio Diagnostic Systems, Inc. is a leading provider of point-of-care (POC) diagnostic tests and products for infectious disease and related conditions. With a focus on advanced technology and research-based development, the company has created a wide portfolio of products that include clinical laboratory, immunoassay, and molecular assays to detect and diagnose a variety of ailments. Founded in 1988 and headquartered in Medford, New York, Chembio Diagnostic Systems has become a widely recognized leader in offering reliable and comprehensive POC testing solutions.
The company produces tests for a variety of infectious diseases, including HIV, Syphilis, Malaria, Chagas, and Zika, and offers a large selection of rapid tests for medical professionals. Chembio Diagnostic also manufactures lateral flow tests, ELISA kits, and other equipment that enable fast, accurate diagnosis in clinical laboratories and hospitals. The company's products are designed for professional use and are readily accepted around the world in both developed and developing countries. The products are available in formats such as dipstick, cassette, and card for a simple, streamlined process.
Chembio Diagnostic strives to deliver reliable, cost-effective testing solutions with exceptional performance. The company focuses on providing high-quality products and services to its worldwide customer base, including clinicians, diagnostics laboratories, research institutions, hospitals and public health organizations. Each test is designed to be simple to perform, reliable and accurate to ensure the best patient care. Chembio provides superior customer service and is committed to helping its customers succeed. Customers rely on the company's expertise and trust in its products, making it a trusted name in POC diagnostics.